Evidence of subpopulations with different levels of insulin resistance in women with polycystic ovary syndrome

Human Reproduction (Oxford, England), 22(11), 2974-2980

DOI 10.1093/humrep/dem302

Abstract

Background

Polycystic ovary syndrome (PCOS) is non-uniformly associated with insulin resistance (IR). We examined IR in women with PCOS.

Methods

Sixty-nine PCOS women were subjected to the insulin suppression test (IST) to determine their steady-state plasma glucose (SSPG) as a direct measure of insulin sensitivity.

Results

SSPG exhibited a multimodal distribution suggesting the existence of subpopulations. The heterogeneous distribution of plasma glucose at 180 min (P = 0.011), with three modes, suggested differences in the plasma glucose level trajectories during the IST. Hence, the population was separated into three groups: (i) (n = 33), subjects with SSPG < or = 152.5 mg/dl, corresponding to the first to fifth deciles; (ii) (n = 29), subjects in the interval 152.5 mg/dl < SSPG < or = 300 mg/dl; (iii) (n = 7), subjects with SSPG > 300 mg/dl, corresponding to the tenth decile. Plasma glucose distributions at 180 min showed differences in their mean values and ranges among groups (P < 0.0001). The trajectories of the groups differed significantly during the IST (P < 0.0001).

Conclusions

insulin sensitivity in our patients exhibited a discontinuous distribution, implying that PCOS is a heterogeneous disorder possessing subpopulations regarding IR.

Topics

pcos insulin resistance subpopulations, insulin suppression test pcos, steady-state plasma glucose pcos, insulin sensitivity heterogeneity polycystic ovary, pcos metabolic phenotypes, insulin resistance classification pcos, glucose intolerance pcos women, pcos subgroups metabolic, targeted pcos treatment protocols, hyperandrogenism insulin resistance, pcos heterogeneous disorder

Cite this article

Vigil, P., Contreras, P., Alvarado, J. L., Godoy, A., Salgado, A. M., & Cortés, M. E. (2007). Evidence of subpopulations with different levels of insulin resistance in women with polycystic ovary syndrome. *Human reproduction (Oxford, England)*, *22*(11), 2974-2980. https://doi.org/10.1093/humrep/dem302

Related articles